Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedCap is a Swedish investment firm that specializes in acquiring and developing small to medium-sized life science companies, primarily in Northern Europe. The company operates through three main business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap's strategy involves active ownership to drive growth and profitability in its portfolio companies, which provide a range of medical equipment, healthcare services, and pharmaceutical products. Notable subsidiaries include Unimedic Pharma, which focuses on specialty pharmaceuticals and contract manufacturing, and Abilia, a leader in assistive technology. The group is publicly traded on Nasdaq Stockholm and focuses on companies with proven business models and strong market positions. By providing capital and strategic expertise, MedCap aims to build sustainable value within the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedCap.